Advances in genetic engineering have placed synthetic biology at a prime position to develop new products, materials, and services that could contribute to the 2030 UN Sustainable Development goals. These include novel materials for water purification, new bio-based products to replace toxic industrial chemicals, and engineered organisms for bioremediation. Supporting the development of synthetic biology initiatives in developing countries is needed to ensure these benefits are open to all.
Extending synthetic biology's reach
Synthetic biology could contribute to eight Sustainable Development Goals (Table 1) . These contributions range from the development of new products through the exploitation of biological materials (e.g.
proteins, carbohydrates, surfactants) to new innovations that support the restoration of ecosystem services. Four areas where synthetic biology could contribute most are:
• reducing the use of harmful industrial chemicals by providing biologically-based alternatives • cleaning up environmental pollutants • increasing crop productivity and soil health • replacing synthetic, non-renewable materials with those derived from organic sources.
These contributions coincide with Goals 6, 9, 14 and 15. While some of the potential applications listed in Table 1 may seem far-fetched, they are grounded in recent scientific advances. These include the production of bioplastics from wheat proteins, potato starch, and bacterial storage compounds (polyhydroxyalkanoates, PHAs) [5] [6] [7] ; the development of sensors based on odorant-binding proteins, neural receptors, and RNAs from a wide range of organisms 8, 9 ; and the creation of new pigments by reengineering the proteins responsible for the optical properties of silica and cellulose. [10] [11] [12] In order to ensure fundamental research is translated into usable products and services, several changes within synthetic biology practice are needed. These changes include overcoming the technical issues of scaling up; increasing dialogue between scientists, NGOs, and industry during the innovation process to ensure usefulness of the final product/service); and reducing the risk associated with high-risk high-reward research to attract investment. Africans to use this knowledge to build a bio-based economy. 13 In cases like these, synthetic biology could be used to increase the yield of plant natural products, reduce susceptibility of crops to pathogens, or to develop completely new products that address needs within their local communities. On the whole, innovations from synthetic biology could lead to the rise of more sustainable cities and communities (Goal 11). In this scenario, low-carbon, degradable, biologically-derived products, from sunscreen and packaging material, would be present in everyday life. Synthetic biology could also contribute to reducing waste within current biotech manufacturing practices (Goal 12). While the amount of plastic waste for industrial manufacturing is unclear, the estimated waste produced by academic science departments lends some insight into this problem. In 2015, researchers from the University of Exeter estimated that 5.5 million tons of plastic were produced annually by 20,500 labs worldwide. 
Industrial innovation
Dyes produced from silica diatom frustles exploit structural color to replace Azo dyes used in the textile industry Reduce risk; identify key industrial chemicals and dyes that could be replaced by synthetic counterparts
Reduced inequalities
Gene synthesis companies automatically apply designated benefit sharing charge for the use of certain genetic materials Promote access to resources (e.g. gene synthesis, vectors, lab equipment) needed for synthetic biology in non-Western countries; engage with policy makers to develop new policy on the use of organisms and genetic sequences in synthetic biology applications
Sustainable cities and communities
Products made using synthetic biology are found in everyday life
Raise public education and awareness of the social benefits of synthetic biology
Responsible production and consumption
Industrial chasses use biosynthetic pathways for waste valorization as a source of energy instead of glucose and nitrogen
Reduce the use of plastics and antibiotics; switch to using waste and light for industrial production of recombinant proteins
Life below water
Paper-based biosensors based on glutamte sensors from Bacillus subtilus detect algal neurotoxins in fish and shellfish to prevent human deaths
Life on land
Bacteria and plants are engineered to remove polyaromatic hydrocarbons and polychlorinated biphenyls from polluted land
Develop new tools to allow for the safe use of bioengineered organisms in the environment to clean up toxins, restore degraded landscapes, and improve agricultural productivity anaerobic bioreactors) could increase the sustainability of biomanufacturing processes. The overuse of antibiotics within biomanufacturing (as a selection tool for identifying successfully transformed organisms) may also contribute to growing rates of antibiotic resistance. 15 Using chromoproteins as indicators of transformation is one example of a small change in practice that could have wider socioecological benefits (reducing the rise of global antimicrobial resistance). 16 Finally, developing industrial chasses that use waste (e.g. lignocellulosic materials) or light for energy would contribute to the development of more circular bioeconomies.
17, 18
The need for diversity and knowledge exchange
Harnessing synthetic biology to build more sustainable bioeconomies can and should be open to all.
However, greater inclusiveness in synthetic biology is needed to achieve this goal. To date, synthetic Increased knowledge exchange could also jump-start bio-based industries in developing economies. This knowledge exchange could be between academics, between academics and local communities, and between industry and non-industrial partners. This would increase local capacity for genetic engineering while supporting the development of local bioeconomies. Activities which could promote such ventures include:
• international exchange programs to promote training in low economic development areas • providing non-western universities with equipment needed to conduct synthetic biology research • supporting synthetic biology start-ups through partnerships with established universities or industries.
The University of Cambridge's Open Plant initiative (which promotes sharing tools, resources, and knowledge in plant biotechnology and has provided grants to start synthetic biology labs in Kenya and Nigeria) 20 and the MIT spin out Amino Labs (which produce small, inexpensive, all-in-one kits for doing synthetic biology for schools and researchers in Africa) 21 are good examples of recent work to increase inclusion and diversity in synthetic biology but more work remains to be done.
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Benefits and risk
Synthetic biology could usher in significant changes for the betterment of society: improved sanitation, faster diagnostics, more resilient crops, and new ventures. However, synthetic biology also poses two key risks to establishing more sustainable societies: (1) the exploitation of natural resources from developing countries for commercial gain without ensuring the country of origin for a given resource received compensation and (2) the reduction of global biodiversity through the introduction of genetically modified organisms into the environment as crops, bioremediation tools, or forms of biocontrol.
If left unchecked, synthetic biology-based industries could exploit the genetic resources of non-Western countries by producing synthetic versions of natural products, thereby increasing global inequality. An estimated 7,500 farmers grow Artemisia annua in East Africa, 200,000 farmers harvest vanilla (Vanilla planifolia) in the tropics, and 3 million farmers grow oil palm (Elaeis guineensis) globally, all compounds now produced using synthetic biology. 22 , 23 The competitive production of steviol glycosides by major chemical companies (e.g. Cargil, Evolva) is a prime example of a synthetic natural product on its way to replacing its living counterpart that has received little attention (Fig. 3) . The stevia plant was traditionally used by indigenous Guarani people of Brazil; an ethnographer in the early 20 th century recorded its use as a sweetener and later it was massed produced in Japan in the 1970s as an alternative to sugar (particularly for diabetics). 24 Today the biosynthetic pathway to produce steviol glycosides is known and there are over 20 patents (many by major food companies) on compounds from the plant and synthetic variations as the market for the sweetener increases. 25 To date, the Guarani people haven't received any benefits from the commercial use of their traditional knowledge and natural resources. Although no synthetically produced versions of natural products have replaced natural versions in recent years (including stevia), the collapse of the indigo market in the early 20 th century after the production of synthetic indigo from aniline illustrates that synthetic products can replace their natural counterparts if the market price is significantly lower. 26 Additional quantitative research and data modeling is needed to determine whether synthetic natural products are currently affecting the production, distribution and sale of traditionally produced natural products. The use of genetically altered organisms could also have a negative impact on global biodiversity in several ways. Genetically altered crops can transfer foreign genes to non-GM varieties and crop wild relatives though wind pollination. 27 In major economic crops like oilseed rape, experimental evidence has shown that foreign genes can spread to plants 2 km away. 28 This could alter plant communities by favoring one species over another and could disrupt the vertebrate and invertebrate food webs in which they are embedded. For example, experimental models suggest that the introduction of genetically modified herbicide-tolerant (GMHT) crops can reduce weed populations and has the potential to greatly reduce the abundance of seed-eating birds. 29 Some research also suggests that genetically modified crops could alter soil microbial communities by shifting microbial community composition in favor of species that can metabolize root exudates from genetically-modified plants. 30 Recent advances in genetic engineering, namely gene drives, have also greatly enhanced our ability to affect wider, more diverse populations of wild organisms. Such drives use Crispr/cas9 systems to self-replicate through a population, eliminating key genes involved in fertility and reproduction along the way. 31, 32 This technology has the potential to eradicate pests that cause disease (e.g. malaria, Dengue) and damage crops (e.g. locusts, rats). 33 However, eliminating wild organisms considered "pests" using gene drives could also disrupt local food chains in unforeseen ways or reduce populations of the targeted species in areas where they are not causing harm to human welfare. 34, 35 The risks from synthetic biology should not present a barrier to the use of these technologies to achieve sustainability goals. Instead, these risks should be identified and mitigated. Within the field of synthetic biology there is a strong commitment in developing containment systems for genetically modified organisms. These include insertion of foreign genes into organelle genomes, 36 the dependence of engineered organisms on supplied nutrients for survival (e.g. unnatural amino acids), 37 the introduction of 'kill-switches' to immediately remove engineered organisms from the environment, 38 and the use of localized (as opposed to global) gene drives that successively lose power with over time (daisy-chain drives). 32, 39, 40 Legislation touching upon many aspects of synthetic biology-from organism engineering to field trials--is also growing and have been extensively reviewed elsewhere. [41] [42] [43] For example, the Nagoya Protocol regulates the use of digital genetic sequence data while national governments regulate the release of genetically modified crops and other organisms into the environment. In 2018, the IUCN developed a task force to address the above issues (the use of digital sequence data, natural resources and release of genetically modified organisms into the environment, all in regards to their impact on global biodiversity) which may provide new opportunities to strengthen policies around the above issues. 44 Potential amendments could include:
• the introduction of a ban on the production of compounds from certain rare or nationally significant organisms
• instigating a specific 'tax' on the use of genes which come from a list of priority or protected organisms
• developing new risk assessments and GIS platforms integrating biological and environmental data to evaluate the potential benefits and damages of using modified plants and other organisms in a given area
• implementing changes to the Nagoya protocol that mandate biotech companies focusing on natural resources have an Ethics officer to handle issues of intellectual property and genetic resources
• developing new national approval processes for bio-based products which must be approved and certified by a centralized regulating authority to ensure fair-use policies and benefit agreements found in agreements like the Nagoya Protocol are upheld Such changes, although small, could ensure all nations reap the benefits of synthetic biology with minimal harm to the availability and quality of national natural resources and ecosystem services.
The challenge
We have just over a decade to reach the UN's 2030 Sustainable Development Goals. If synthetic biology will play a part in reaching them, significant changes will need to be made to synthetic biology as a technology and as a means to drive, possibly ground breaking, social change. At the moment, synthetic biology is confined to academic labs and startups. Less than 70 synthetic biology-derived products are on the market worldwide. 45 The greatest challenges to widespread adoption of bioinspired materials and services in everyday life will be barriers to scaling up (which include lack of start-up funding and technological challenges such as reproducibility and uniformity of biological materials), regulation around the use of genetic materials in the natural environment, public acceptance of these innovations, and ensuring fairness, inclusion and opportunity in synthetic biology as the field rapidly advances and the gap between Western and non-Western technology widens. Synthetic biologists will need to capture the imagination of the general public and the support of policy makers in order to make this vision for a more sustainable future a reality.
